National recommendations based on scientific evidence and opinions of experts on the use of methotrexate in rheumatic disorders, especially in rheumatoid arthritis. Results of the 3E Initiative from Brazil;Recomendações nacionais baseadas em evidências científicas e opiniões dos especialistas sobre o uso do metotrexato nas doenças reumáticas, especialmente na artrite reumatoide. Resultados da iniciativa 3E do Brasil

Revista Brasileira de Reumatologia

Volumn 49, Issue 4, 2009, Pages 346-361

  Pereira, Ivânio Alves ^a   Cruz, Boris Afonso ^b   Xavier, Ricardo Machado ^c   Pinheiro, Geraldo Da Rocha Castelar ^d   Titton, David Cesar ^e   Giorgi, Rina Dalva Neubarth ^f   Da Rocha, Francisco Airton Castro ^g   Laurindo, Ieda Maria Magalhães ^c   Bértolo, Manoel Barros ^h   Dougados, Maxime ⁱ  

^a Hospital Universitário UFSC   (Brazil)

^b Instituto Biocor de Belo Horizonte   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Hospital Universitário UERJ

^e Hospital Das Clínicas UFPR

^f HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^g Hospital Das Clínicas UFCE

^h UNIVERSITY OF CAMPINAS   (Brazil)

ⁱ NONE   (France)

Author keywords

Methotrexate; Rheumatoid arthritis

Indexed keywords

ALCOHOL; AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FOLIC ACID; FOLINIC ACID; HEPATITIS B VACCINE; ILLICIT DRUG; INFLUENZA VACCINE; LEFLUNOMIDE; METHOTREXATE; PLACEBO; PNEUMOCOCCUS VACCINE; SALAZOSULFAPYRIDINE;

ARTICLE; BLOOD CELL COUNT; BRAZIL; CLINICAL PRACTICE; CLINICAL TRIAL; COCHRANE LIBRARY; COMORBIDITY; CONTRACEPTION; DELPHI STUDY; DERMATOMYOSITIS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; ELECTIVE SURGERY; EMBASE; GASTROINTESTINAL TOXICITY; GIANT CELL ARTERITIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER DISEASE; LIVER TOXICITY; LOW DRUG DOSE; MEDLINE; POLYMYOSITIS; PRACTICE GUIDELINE; PSORIATIC ARTHRITIS; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SEROLOGY; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TREATMENT PLANNING; VASCULITIS;

EID: 70449688246     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0482-50042009000400003     Document Type: Article

References (65)

1. Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M et al. EULAR Recommendations for the Management of Early Arthritis: Report of a Task Force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:34-45. (Pubitemid 46044858)
2. Sidiropoulos PI, Hatemi G, Song IH, Avouac J, Collantes E, Hamuryudan V et al. Evidence-based Recommendations for the Management of Ankylosing Spondylitis: Systematic Literature Search of the 3E Initiative in Rheumatology Involving a Broad Panel of Experts and Practicing Rheumatologists. Rheumatology (Oxford) 2008;47:355-361 (Pubitemid 351267206)
3. Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J et al. Multinational Evidence-Based Recommendations for the Use of Methotrexate in Rheumatic Disorders with a Focus on Rheumatoid Arthritis: Integrating Systematic Literature Research and Expert Opinion of a Broad International Panel of Rheumatologists in the 3E Initiative. Ann Rheum Dis 25/11/2008, 10.1136/ard.2008.094474.
4. van Tulder M, Furlan A, Bombardier C, Bouter L, Koes B, Malmivaara A et al. Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group. Spine 2003;28:1290-1299 (Pubitemid 36734620)
5. http://ww.cebm.net/index.aspx?o=1025. Acessado em Março/2008.
6. Furst D, Koehnke R, Burmeister LF, Kohler J, Cargill I. Increasing Methotrexate Effect with Increasing Dose in the Treatment of Resistant Rheumatoid Arthritis. J Rheumatol 1989;16:313-320 (Pubitemid 19104569)
7. Schnabel A, Reinhold-Keller E, Willmann V, Gross WL. Tolerability of Methotrexate Starting with 15 or 25 mg/week for Rheumatoid Arthritis. Rheumatol Int 1994;14:33-38 (Pubitemid 24189748)
8. Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ et al. Intensive Treatment with Methotrexate in Early Rheumatoid Arthritis: Aiming for Remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:1443-1449
9. Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V et al. Dose Escalation of Parenteral Methotrexate in Active Rheumatoid Arthritis that has been Unresponsive to Conventional Doses of Methotrexate: a Randomized, Controlled Trial. Arthritis Rheum 2004;50:364-371 (Pubitemid 38198819)
10. Braun J, Kästner P, Flaxenberg P, Währisch J, Hanke P, Demary W et al. Comparison of the Clinical Efficacy and Safety of Subcutaneous Versus Oral Administration of Methotrexate in Patients with Active Rheumatoid Arthritis. Arthritis Rheum 2008;58:73-81.
11. Visser K, van der Heijde D. Incidence of Liver Enzyme Elevations and Liver Biopsy Abnormalities during Methotrexate Treatment in Rheumatoid Arthritis: A Systematic Review of the Literature. Arthritis Rheum 2008;58 (suppl):S557.
12. Shergy WJ, Polisson RP, Caldwell DS, Rice JR, Pisetsky DS, Allen NB. Methotrexate-associated Hepatotoxicity: Retrospective Analysis of 210 patients with Rheumatoid Arthritis. Am J Med 1988;85:771-774
13. Katchamart W, Ortiz Z, Shea B, Tugwell P, Bombardier C. Folic Acid and Folinic Acid for Reducing Side Effects in Patients Receiving Methotrexate for Rheumatoid Arthritis (an Update Systematic Review and Metaanalysis). Arthritis Rheum 2008;58 (suppl):S473.
14. Ros S, Juanola X, Condom E, Canas C, Riera J, Guardiola J et al. Light and Electron Microscopic Analysis of Liver Biopsy Samples from Rheumatoid Arthritis Patients Receiving Long-Term Methotrexate Therapy. Scand J Rheumatol 2002;31:330-336 (Pubitemid 35398741)
15. Tilling L, Townsend S, David J. Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis. Clin Drug Investig 2006;26:55-62. (Pubitemid 43275699)
16. Espinoza LR, Zakraoui L, Espinoza CG, Gutiérrez F, Jara LJ, Silveira LH et al. Psoriatic Arthritis: Clinical Response and Side Effects to Methotrexate Therapy. J Rheumatol. 1992;19:872-877
17. Choi HK, Hernan MA, Seeiger JD, Robins JM, Wolge F. Methotrexate and Mortality in Patients with Rheumatoid Arthritis: a Prospective Study. Lancet 2002;359:1173-1177 (Pubitemid 34304256)
18. van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE. Disease Modifying Antirheumatic Drugs are Associated with a Reduced Risk for Cardiovascular Disease in Patients with Rheumatoid Arthritis: a Case Control Study. Arthritis Res Ther 2006;8:R151.
19. Wolfe F and Michaud K. Lymphoma in Rheumatoid Arthritis: the Effect of Methotrexate and Anti-Tumor Necrosis Factor Therapy in 18,572 Patients. Arthritis Rheum 2004;50:1740-1751 (Pubitemid 38725085)
20. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in Rheumatoid Arthritis Patients Treated with Methotrexate: a 3-year Prospective Study in France. Blood 2002;99:3909-3915 (Pubitemid 35332027)
21. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Predictors of Infection in Rheumatoid Arthritis. Arthritis Rheum 2002;46:2294-2300
22. Wolfe F, Michaud K, Chakravarty EF. Rates and Predictors of Herpes Zoster in Patients with Rheumatoid Arthritis and Non-Inflammatory Musculoskeletal Disorders. Rheumatology (Oxford) 2006;45:1362-1745 (Pubitemid 44605471)
23. Katchamart W, Trudeau J, Phumethum V, Bombardier C. The Efficacy and Toxicity of Methotrexate Combination versus Monotherapy in Rheumatoid Arthritis: A Metaanalysis. Arthritis Rheum 2008;58:(suppl-ACR 2008).
24. Capell HA, Madhok R, Porter D, Munro R, McInnes I, Hunter J et al. Combination Therapy with Sulphasalazine and Methotrexate is More Effective than Either Drug Alone in Patients with Rheumatoid Arthritis with a Suboptimal Response to Sulphasalazine: Results from the Double-Blind Placebo-Controlled MASCOT study. Ann Rheum Dis 2007; 66:235-241 (Pubitemid 46226060)
25. Kremer JM, Genovese MC, Cannon GW, Caldwell JR, Cush JJ, Furst de et al. Concomitant Leflunomide Therapy in Patients with Active Rheumatoid Arthritis Despite Stable Doses of Methotrexate. A Randomized, Double-Blind, Placebo-Controlled Trial. Ann Intern Med 2002;137:726-733
26. Tugwell P, Pincus T, Yocum D, Stein M, Gluck O, Kraag G et al. Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis. The Methotrexate-Cyclosporine Combination Study Group. N Engl J Med 1995;333:137-141
27. van Ede AE, Laan RF, Rood MJ, Huizinga TW, van de Laar MA, van Denderen CJ et al. Effect of Folic or Folinic Acid Supplementation on the Toxicity and Efficacy of Methotrexate in Rheumatoid Arthritis: a Forty-Eight Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Arthritis Rheum 2001;44:1515-1524
28. Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, Krumdieck CL et al. The Effect of Folic Acid Supplementation on the Toxicity of Low-Dose Methotrexate in Patients with Rheumatoid Arthritis. Arthritis Rheum 1990;33:9-18.
29. Morgan SL, Baggott JE, Vaughn WH, Austin JS, Veitch TA, Lee JY et al. Supplementation with Folic Acid during Methotrexate Therapy for Rheumatoid Arthritis. A Double-Blind, Placebo-Controlled Trial. Ann Intern Med 1994;121:833-841
30. Griffith SM, Fisher J, Clarke S, Montgomery B, Jones PW, Saklatvala J et al. Do Patients with Rheumatoid Arthritis Established on Methotrexate and Folic Acid 5mg Daily Need to Continue Folic Acid Supplements Long Term? Rheumatology (Oxford) 2000;39:1102-1109
31. Buckley LM, Vacek PM, Cooper SM. Administration of Folinic Acid after Low Dose Methotrexate in Patients with Rheumatoid Arthritis. J Rheumatol 1990;17:1158-1161 (Pubitemid 20334691)
32. Kremer JM, Alarcon GS, Lightfoot RW Jr., Willkens RF, Furst DE, Williams HJ et al. Methotrexate for Rheumatoid Arthritis. Suggested Guidelines for Monitoring Liver Toxicity. American College of Rheumatology. Arthritis Rheum 1994;37:316-328
33. Erickson AR, Reddy V, Vogelgesang SA, West SG. Usefulness of the American College of Rheumatology Recommendations for Liver Biopsy in Methotrexate-Treated Rheumatoid Arthritis Patients. Arthritis Rheum 1995;38:1115-1119
34. Guidelines for Monitoring Drug Therapy in Rheumatoid Arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis Rheum1996;39:723-731
35. Bértolo MB, Brenol CV, Schainberg CG, Neubarth F, Lima FAC, Laurindo IM et al. Atualização do Consenso Brasileiro no Diagnóstico e Tratamento da Artrite Reumatoide. Update on the Brazilian Consensus for the Diagnosis and Treatment of Rheumatoid Arthritis. Rev Bras Reumatol 2007;47:151-159
36. The Effect of Age and Renal Function on the Efficacy and Toxicity of Methotrexate in Rheumatoid Arthritis. Rheumatoid Arthritis Clinical Trial Archive Group. J Rheumatol 1995;22:218-223
37. Alarcon GS, Kremer JM, Macaluso M, Weinblatt ME, Cannon GW, Palmer WR et al. Risk Factors for Methotrexate-Induced Lung Injury in Patients with Rheumatoid Arthritis. A Multicenter, Case-Control Study. Methotrexate-Lung Study Group. Ann Intern Med 1997;127:356-364 (Pubitemid 27362743)
38. Golden MR, Katz RS, Balk RA, Golden HE. The Relationship of Preexisting Lung Disease to the Development of Methotrexate Pneumonitis in Patients with Rheumatoid Arthritis. J Rheumatol 1995;22:1043-1047
39. Beyeler C, Jordi B, Gerber NJ, Hof VIM. Pulmonary Function in Rheumatoid Arthritis Treated with Low-Dose Methotrexate: a Longitudinal Study. Br J Rheumatol 1996;35:446-452 (Pubitemid 126719474)
40. Sany J, Anaya JM, Canovas F, Combe B, Jorgensen C, Saker S et al. Influence of Methotrexate on the Frequency of Postoperative Infectious Complications in Patients with Rheumatoid Arthritis. J Rheumatol 1993;20:1129-1132 (Pubitemid 23278162)
41. Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and Early Postoperative Complications in Patients with Rheumatoid Arthritis undergoing Elective Orthopaedic Surgery. Ann Rheum Dis 2001;60:214-217 (Pubitemid 32260601)
42. Carpenter MT, West SG, Vogelgesang SA, Casey Jones DE. Postoperative Joint Infections in Rheumatoid Arthritis Patients on Methotrexate Therapy. Orthopedics 1996;19:207-210 (Pubitemid 26089384)
43. Murata K, Yasuda T, Ito H, Yoshida M, Shimizu M, Nakamura T. Lack of Increase in Postoperative Complications with Low-Dose Methotrexate Therapy in Patients with Rheumatoid Arthritis undergoing Elective Orthopedic Surgery. Mod Rheumatol 2006;16:14-19 (Pubitemid 43298786)
44. Chakravarty EF, Sanchez-yamamoto D, Bush TM. The Use of Disease Modifying Antirheumatic Drugs in Women with Rheumatoid Arthritis of Childbearing Age: a Survey of Practice Patterns and Pregnancy Outcomes. J Rheumatol 2003;30:241-246
45. Mahr AD, Jover JA, Spiera RF, Hernandez-Garcia C, Fernandez-Gutierrez B, Lavalley MP et al. Adjunctive Methotrexate for Treatment of Giant Cell Arteritis: an Individual Patient Data Meta-Analysis. Arthritis Rheum 2007;56:2789-2797 (Pubitemid 47237299)
46. Ferraccioli G, Salaffi F, De Vita S, Casatta L, Bartoli E. Methotrexate in Polymyalgia Rheumatica: Preliminary Results of an Open, Randomized Study. J Rheumatol 1996;23:624-628 (Pubitemid 26132846)
47. Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C et al. Prednisone plus Methotrexate for Polymyalgia Rheumatica: a Randomized, Doubleblind, Placebo-Controlled Trial. Ann Intern Med 2004;141:493-500. (Pubitemid 39350239)
48. Fortin PR, Abrahamowicz M, du Berger R, Nayak V, Neville C, Liang MH. Study of Methotrexate in Lupus Erythematosus (SMILE): Significant Decreased Disease Activity and Steroid Sparing Effect in Patients without Damage. Arthritis Rheum 2001;44 (suppl):S387.
49. Carneiro JR, Sato EI. Double Blind, Randomized, Placebo Controlled Clinical Trial of Methotrexate in Systemic Lupus Erythematosus. J Rheumatol 1999;26:1275-1279 (Pubitemid 29268077)
50. Ramanan AV, Campbell-Webster N, Ota S, Parker S, Tran D, Tyrrell PN et al. The Effectiveness of Treating Juvenile Dermatomyositis with Methotrexate and Aggressively Tapered corticosteroids. Arthritis Rheum 2005;52:3570-3578 (Pubitemid 41612226)
51. Dawson JK, Desmond J, Graham DR, Fewins HE, Lynch MP. Investigation of the Chronic Pulmonary Effects of Low-Dose Oral Methotrexate in Patients with Rheumatoid Arthritis: a Prospective Study Incorporating HRCT Scanning and Pulmonary Function Tests. Rheumatology (Oxford) 2002;41:262-267 (Pubitemid 34537861)
52. Alarcon GS, Kremer JM, Macaluso M, Weinblatt ME, Cannon GW, Palmer WR et al. Risk Factors for Methotrexate-Induced Lung Injury in Patients with Rheumatoid Arthritis. A Multicenter, Case-Control Study. Methotrexate-Lung Study Group. Ann Intern Med 1997;127:356-364 (Pubitemid 27362743)
53. Bartram SA. Experience with Methotrexate-Associated Pneumonitis in Northeastern England. Arthritis Rheum 1998;41:1327-1328
54. Ohosone Y, Okano Y, Kameda H, Fujii T, Hama N, Hirakata M et al. Clinical Characteristics of Patients with Rheumatoid Arthritis and Methotrexate Induced Pneumonitis. J Rheumatol 1997;24:2299-2303 (Pubitemid 28005125)
55. Hilliquin P, Renoux M, Perrot S, Puéchal X, Menkes CJ. Ocurrence of Pulmonary Complications during Methotrexate Therapy in Rheumatoid Arthritis. British J Rheumatol 1996;35:441-445 (Pubitemid 126719473)
56. Golden MR, Katz RS, Balk RA, Golden HE. The Relationship of Pre-Existing Lung Disease to the Development of Methotrexate Pneumonitis in Patients with Rheumatoid Arthritis. J Rheumatol 1995;22:1043-1047
57. Carroll GJ, Thomas R, Phatouros CC, Atchison MH, Leslie AL, Cook NJ et al. Incidence, Prevalence and Possible Risk Factors for Pneumonitis in Patients with Rheumatoid Arthritis Receiving Methotrexate. J Rheumatol 1994;21:51-54 (Pubitemid 24044917)
58. Chalmers A, Scheifele D, Patterson C, Williams D, Weber J, Shuckett R et al. Immunization of Patients with rheumatoid arthritis against influenza: a Study of Vaccine Safety and Immunogenicity. J Rheumatol 1994;21:1203-1206 (Pubitemid 24234652)
59. Fomin I, Caspi D, Levy V, Shalev Y, Mendelson E, Paran D et al. Vaccination against Influenza in rheumatoid arthritis: the Effect of Disease Modifying Drugs, including TNF Alpha Blockers. Ann Rheum Dis 2006;65:191-194 (Pubitemid 43131992)
60. Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P. Influenza Vaccination as Model for Testing Immune Modulation Induced by Anti-TNF and Methotrexate Therapy in RA patients. Rheumatology (Oxford) 2007;46:608-611 (Pubitemid 46523304)
61. Oren S, Mendelboim M, Brawn Y, Paran D, Ablin J, Litinsky I et al. Vaccination against Influenza in RA Patients: The Effect of Rituximab in Humoral Response. Ann Rheum Dis 2007;66(Supp II):363.
62. Elkayam O, Paran D, Caspi D, Litinsky I, Yaron M, Charboneau D et al. Immunogenicity and Safety of Pneumococcal Vaccination in Patients with RA or SLE. Clin Infec Dis 2002;34:147-153
63. Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P et al. Influence of Methotrexate, TNF Blockers and Prednisolone on Antibody Responses to Pneumococcal Polysaccharide Vaccine in Patients with RA. Rheumatology 2006;45:106-111
64. Elkayam O, Yaron M, Caspi D. Safety and Efficacy of Vaccination against Hepatitis B in Patients with RA. Ann Rheum Dis 2002;61:623-662 (Pubitemid 34717774)
65. Ravikumar R, Owen T, Barnard J, Almudevar A, Anolik J, Looney J et al. Anti-TNF Therapy in RA Patients Alters Hepatitis B Vaccine Responses. Poster presented at the ACR meeting, 2006.